尾加压素Ⅱ在心脏重构中的作用及其信号转导机制
摘要
尾加压素Ⅱ作为目前为止哺乳动物中最有效的血管收缩剂,除具有血管舒缩活性、心脏变力、变时作用外,新近研究发现其在心脏重构中亦发挥重要作用。
出处
《中国循环杂志》
CSCD
北大核心
2005年第6期477-479,共3页
Chinese Circulation Journal
参考文献20
-
1Pearson D,Shively JE,Clark BR,et al.Urotensin Ⅱ:a somatostatin-like peptide in the caudal neurosecretory system of fishes.Proc Natl Acad Sci,1980,77:5021-5024.
-
2Coulouarn Y,Lihrmann I,Jegou S,et al.Cloning of the cDNA encoding the Urotensin Ⅱ precursor in frog and human reveals intense expression of the Urotensin Ⅱ gene in motoneurons of the spinal cord.Proc Natl Acad Sci,1998,95:15803-15808.
-
3Ames RS,Sarau HM,Chambers JK,et al.Human urotensin Ⅱis a potent vasoconstrictor and agonist for the orphan receptor GPR14.Nature,1999,401:282-286.
-
4Stirrat A,Gallagher M,Douglas SA,et al.Potent vasodilator responsesto human urotensin Ⅱ in human pulmonary and abdominal resistance arteries.Am J Physiol Heart Circ Physiol,2001,280:925-928.
-
5Bottrill FE,Douglas SA,Hiley CR,et al.Human urotensin Ⅱis an endothelium-dependent vasodilator in rat small arteries.Br J Pharmacol,2000,130:1865-1870.
-
6Lim M,Honisett S,Sparkes CD,et al.Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure.Circulation,2004,109(10):1212-1214.
-
7Watson AM,Lambert GW,Smith KJ,et al.Urotensin Ⅱ acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions.Hypertension,2003,42:373-379.
-
8Zhu YZ,Wang ZJ,Zhu YC,et al.Urotensin Ⅱ causes fatal circulatory collapse in anesthesized monkeys in vivo:a "vasoconstrictor" with a unique hemodynamic profile.Am J Physiol Heart Circ Physiol,2004,286(3):H830-836.
-
9Richards AM,Nicholls MG,Mainchbury JG,et al.Plasma urotensin Ⅱ in heart failure.Lancet,2002,360:545-546.
-
10Ng LL,Loke I,O'Brien RJ,et al.Plasma urotensin in human systolic heart failure.Circulation,2002,106:2877-2880.
-
1吴祥声.降钙素基因相关肽[J].国外医学(临床生物化学与检验学分册),1994,15(5):200-202. 被引量:15
-
2钟云权.β-受体阻滞剂在心力衰竭中的应用现状[J].现代医药卫生,2005,21(14):1841-1842.
-
3胡大一.抗心律失常药物的合理使用[J].中华心律失常学杂志,1998,2(B09):73-74. 被引量:1
-
4龚开政.内皮素与充血性心力衰竭的研究进展[J].国外医学(老年医学分册),2002,23(1):15-18. 被引量:2
-
5赵明中,郭晓铭.β受体阻滞剂在慢性心力衰竭中的应用[J].中国社区医师,2006,22(13):10-11. 被引量:5
-
6那开宪,余平.应走出β-受体阻滞剂治疗心力衰竭的误区[J].中国医刊,2009,44(8):4-7. 被引量:2
-
7Castro R.R.T.,Porphirio G.,Serra S.M.,Nóbrega A.C.L.,姜馨.吡斯的明的胆碱能兴奋作用可防止运动诱发的心肌缺血[J].世界核心医学期刊文摘(心脏病学分册),2005,0(3):39-40.
-
8杨友竹.充血性心力衰竭时血浆神经肽Y水平升高[J].国际心血管病杂志,1989,32(5):317-318.
-
9心肌疾病[J].国外科技资料目录(医药卫生),2001(11):61-64.
-
10Rastan A.J.,Eckenstein J.I.,Hentschel B.,朱冰坡.急性冠状动脉综合征的急诊冠状动脉搭桥术:心脏不停跳方案与常规心脏停跳方案的比较[J].世界核心医学期刊文摘(心脏病学分册),2007,0(1):35-36. 被引量:1